Trial Profile
Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Subjects With Schizophrenia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Sep 2013
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- 21 Sep 2013 New trial record